| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,703 |
3,485 |
$204K |
| 87428 |
|
1,028 |
994 |
$63K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
733 |
718 |
$37K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
559 |
550 |
$28K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
184 |
178 |
$12K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
83 |
82 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
499 |
247 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
428 |
415 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
731 |
712 |
$5K |
| 80053 |
Comprehensive metabolic panel |
467 |
456 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
57 |
57 |
$759.01 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
85 |
82 |
$506.27 |
| 81003 |
|
95 |
92 |
$175.04 |
| 81025 |
|
24 |
24 |
$161.28 |
| 80061 |
Lipid panel |
16 |
16 |
$155.48 |
| 84443 |
Thyroid stimulating hormone (TSH) |
16 |
16 |
$145.60 |
| 1160F |
|
72 |
67 |
$0.00 |
| 3078F |
|
126 |
124 |
$0.00 |
| 99307 |
|
20 |
20 |
$0.00 |
| 1159F |
|
31 |
29 |
$0.00 |
| 3074F |
|
341 |
326 |
$0.00 |
| 1036F |
|
187 |
176 |
$0.00 |
| 3008F |
|
59 |
54 |
$0.00 |
| 3079F |
|
21 |
19 |
$0.00 |